Clinical trial
Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke: An Observational, Prospective and Multicenter Study
NCT02169492 is registered in ClinicalTrials.gov with Codman & Shurtleff as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke: An Observational, Prospective and Multicenter Study
- Lead sponsor
- Codman & Shurtleff
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- May 31, 2017
- Enrollment
- 103 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.